DEMONSTRATE: DRUG EVALUATION IN MELANOMA: ONCOLOGY STUDY AND RESEARCH OF IPILIMUMAB Trademark

Trademark Overview

On Wednesday, June 16, 2010, a trademark application was filed for DEMONSTRATE: DRUG EVALUATION IN MELANOMA: ONCOLOGY STUDY AND RESEARCH OF IPILIMUMAB with the United States Patent and Trademark Office. The USPTO has given the DEMONSTRATE: DRUG EVALUATION IN MELANOMA: ONCOLOGY STUDY AND RESEARCH OF IPILIMUMAB trademark a serial number of 85064237. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 21, 2014. This trademark is owned by Bristol-Myers Squibb Company. The DEMONSTRATE: DRUG EVALUATION IN MELANOMA: ONCOLOGY STUDY AND RESEARCH OF IPILIMUMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
demonstrate: drug evaluation in melanoma: oncology study and research of ipilimumab

General Information

Serial Number85064237
Word MarkDEMONSTRATE: DRUG EVALUATION IN MELANOMA: ONCOLOGY STUDY AND RESEARCH OF IPILIMUMAB
Filing DateWednesday, June 16, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 21, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2011

Trademark Statements

Disclaimer with Predetermined Text"DRUG EVALUATION IN MELANOMA: ONCOLOGY STUDY AND RESEARCH OF IPILIMUMAB"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 21, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, July 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 21, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 31, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 30, 2013EXTENSION 5 GRANTED
Monday, December 16, 2013EXTENSION 5 FILED
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Tuesday, July 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2013EXTENSION 4 GRANTED
Friday, June 14, 2013EXTENSION 4 FILED
Friday, July 12, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 14, 2013TEAS EXTENSION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, November 19, 2012EXTENSION 3 GRANTED
Thursday, November 15, 2012EXTENSION 3 FILED
Thursday, November 15, 2012TEAS EXTENSION RECEIVED
Friday, May 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, May 17, 2012EXTENSION 2 GRANTED
Wednesday, April 25, 2012EXTENSION 2 FILED
Wednesday, May 16, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 25, 2012TEAS EXTENSION RECEIVED
Thursday, November 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, November 1, 2011EXTENSION 1 GRANTED
Tuesday, November 1, 2011EXTENSION 1 FILED
Tuesday, November 1, 2011TEAS EXTENSION RECEIVED
Tuesday, June 14, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 19, 2011PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2011NOTICE OF PUBLICATION
Thursday, March 17, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 17, 2011ASSIGNED TO LIE
Monday, February 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 7, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 7, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 7, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 30, 2010NON-FINAL ACTION MAILED
Wednesday, September 29, 2010NON-FINAL ACTION WRITTEN
Wednesday, September 22, 2010ASSIGNED TO EXAMINER
Monday, June 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 19, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

study research ipilimumab oncology melanoma drug evaluation demonstrate relating pharmaceutical preparations human trials clinical scientific namely conducting